Has Giridhar Vedula, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,565 in general payments to Giridhar Vedula, MD across 38 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Giridhar Vedula, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Giridhar Vedula, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Giridhar Vedula, MD

Transplant Surgery · Atlanta, GANPI 1730387697

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,126 of the $2,565 with a category attached, or 82.9%. It is spread thinly across 16 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $836, 2.2 times the $379 reported in 2019.

$2,565in general payments, 2019–2025

Across 38 payments — averaging $67.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Organox Ltd$517
Transmedics, Inc.$439
Boston Scientific$318
Johnson & Johnson$315
Fujifilm Healthcare Americas Corporation$266
Baxter Healthcare$196
plus $514 from 10 others

What the payments were for

Travel & lodging$43917%
Food & beverage$2,12683%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Organox Ltd	5	$517
Transmedics, Inc.	1	$439
Boston Scientific	2	$318
Johnson & Johnson	3	$315
Fujifilm Healthcare Americas Corporation	2	$266
Baxter Healthcare	5	$196
Bayer	1	$125
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$103
Mallinckrodt Hospital Products Inc.	4	$84
AbbVie	2	$52
Ipsen Biopharmaceuticals, Inc	2	$44
Intercept Pharmaceuticals, Inc.	2	$38
Medtronic	1	$26
Madrigal Pharmaceuticals	1	$18
E.r. Squibb & Sons, L.L.C.	1	$16
Lemaitre Vascular, Inc.	1	$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ORGAN CARE SYSTEM$439
METRA$341
TheraSphere Y90 Glass Microspheres 10 GBq$318
uTASWako AFP-L3$266
Echelon Circular$258
Harmonic$258
EVARREST$258
STRATAFIX$258
No Related Product$129
Stivarga$125

How this compares

$2,565 in reported general payments places this provider in the 55th percentile of 29 transplant surgery providers in Georgia.

See all transplant surgery providers in Georgia →

Medicare billing

Part B allowed, 2024

$58,356

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	22	$84

Paid to pharmacies, not to this prescriber.

Other transplant surgery in Atlanta

Nicole TurgeonAtlanta$130K
Stuart KnechtleAtlanta$88K
Allan KirkAtlanta$80K
Andrew AdamsAtlanta$60K
Evan WeitmanAtlanta$40K
Clark KensingerAtlanta$35K
Juliano RiellaAtlanta$15K
Harrison PollingerAtlanta$9K
Marty SellersAtlanta$4K
Jonathan HundleyAtlanta$4K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →